Recall draft new drugs bill: Industry body

economictimes.indiatimes.com:

Drugs and Cosmetics Act in the monsoon session of the Parliament that starts this week, a key stakeholder says not enough discussions have been held and it should be recalled. The Association of Indian Medical Device Industry (AiMed), wrote to the Union health minister Mansukh Mandaviya on Tuesday, urging to recall the draft bill. “After the initial invitation of comments we have not been invited for any discussions or the revised draft was not shared with us,” said Rajiv Nath, forum co-ordinator, AiMed. Stating that they are “highly dismayed” that the government has tabled the Draft of New Drugs, Medical Devices and Cosmetics Bill, 2022 for introduction, consideration and passing to the Parliament for the monsoon session to regulate drugs and medical devices without even a single meeting with them as major stakeholders, in a letter to Mandaviya, Nath said that the move has been made in a“strange manner”. “The process was highly flawed with conflict of interest to empower regulators to draft the bill without even seeking inputs from MDTAG (Medical Device Technical Advisory Group) and discussion with AiMeD,” he said. He said that it was strange that the ministry and the CDSCO did not consider the recommendation of the Parliamentary Committee 138th Report released on September 12, 2022 that recommended a separate law for medical devices as was being regularly sought by Indian Manufacturers.

Healthcare professionals should serve in districts, villages: Mansukh Mandaviya

Can stem cells cure disease? Here are some answers

New cancer-like rating system introduced for Alzheimer's diagnosis

“Since 1982, the government has been